EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Coronavirus disease 2019 vaccination effectiveness based on the 2021 Japanese dialysis registry

Yuka Sugawara iD, Masao Iwagami iD, Kan Kikuchi, Toyohiro Hashiba iD, Sayaka Yabushita, Munekazu Ryuzaki, Masaomi Nangaku iD

Nephrology · 2024

DOI: 10.1111/nep.14366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology, 2024. Verfasst von Yuka Sugawara und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Endocrinology, The University of Tokyo, Bunkyo-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Registries, Renal Dialysis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The effectiveness of the coronavirus disease (COVID‐19) vaccine in Japanese patients undergoing haemodialysis has previously not been evaluated on a large scale. We analyzed data from the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR), covering nearly all Japanese patients undergoing dialysis (~95% coverage), to examine the association between COVID‐19 vaccination and infection or mortality.

Methods

We used data from the JRDR end‐of‐year surveys conducted in 2020 and 2021, including information on the COVID‐19 vaccination and infection months. COVID‐19 infection incidence and its associated mortality rates based on vaccination status (time updated) and odds ratio (OR) (vaccinated vs. unvaccinated) were estimated monthly from April 2021, when vaccination commenced in Japan.

Results

COVID‐19 infection analysis included 228 865 patients (215 941 vaccinated and 12 924 unvaccinated patients at the end of 2021). The age‐ and sex‐adjusted ORs (aORs) were significantly lower in August, September, October and November 2021, especially in September (aOR [95% confidence interval (CI)]: 0.25 [0.18–0.36]). Additional adjustments for past medical history and laboratory results rarely affected these results. Similarly, in the COVID‐19‐related mortality analysis with 228 731 patients, including 216 781 vaccinated and 11 950 unvaccinated at the end of 2021, COVID‐19‐related mortality risk was significantly lower in the vaccinated group in August, September, October and November (aOR [95% CI]: August, 0.32 [0.12–0.84], September, 0.04 [0.01–0.11]; October, 0.10 [0.01–0.81]; November, 0.05 [0.00–0.79]).

Conclusion

In Japanese patients undergoing haemodialysis, the first or second COVID‐19 vaccine dose was significantly associated with decreased COVID‐19 infection and mortality rates, suggesting its effectiveness in this population. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesRegistriesRenal DialysisVaccine EfficacyAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedEast Asian PeopleIncidenceJapanVaccination

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2coronavirushaemodialysiskidney

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Division of Nephrology and Endocrinology, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
  • Department of Health Services Research, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Division of Nephrology, Shimoochiai Clinic, Tokyo, Japan.
  • Department of Nephrology, Tokyo Saiseikai Central Hospital, Tokyo, Japan.

ORCID-Profile: Yuka Sugawara, Masao Iwagami, Toyohiro Hashiba, Masaomi Nangaku

Förderung

  • Ministry of Health, Labour and Welfare

Zitieren

APA

Sugawara, Y., Iwagami, M., Kikuchi, K., Hashiba, T., Yabushita, S., Ryuzaki, M., & Nangaku, M. (2024). Coronavirus disease 2019 vaccination effectiveness based on the 2021 Japanese dialysis registry. Nephrology. https://doi.org/10.1111/nep.14366

Vancouver

Sugawara Y, Iwagami M, Kikuchi K, Hashiba T, Yabushita S, Ryuzaki M, et al. Coronavirus disease 2019 vaccination effectiveness based on the 2021 Japanese dialysis registry. Nephrology. 2024. doi:10.1111/nep.14366

BibTeX
@article{Sugawara2024,
  author = {Sugawara, Yuka and Iwagami, Masao and Kikuchi, Kan and Hashiba, Toyohiro and Yabushita, Sayaka and Ryuzaki, Munekazu and Nangaku, Masaomi},
  title = {Coronavirus disease 2019 vaccination effectiveness based on the 2021 Japanese dialysis registry},
  journal = {Nephrology},
  year = {2024},
  doi = {10.1111/nep.14366}
}
Kostenlos starten →